Member Info for Gruffell

Just read this in The Times

Retired doctors and nurses who answered calls to help administer vaccines must show 21 separate documents, including certificates that they are trained in countering racism and terrorism, fire safety, conflict resolution, human rights and data security. FFS

No PL75, you are the massive, ignorant pr!que. We are all allowed to express our opinions aloud or quietly. All together now, as loud as we are allowed "You massive male sex organ."

Well its not going to rise for some of us and not for others, you uneducated pillock

This is a cut and paste of the guts of the RNS of 22nd April this year which was the clincher in my decision to make my first investment in Avacta .
As far a I can see nothing of significance has happened since (apart from a house purchase.)
I have been a loyal supporter and sung Avacta's praises in all sorts of places.
But I am losing patience with the lack of progress or even informative progress reports. I am seriously considering moving my albeit modest funds elsewhere.
So far "Thanks for nothing."

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that, in only four weeks and well ahead of schedule, it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen as part of the collaboration with Cytiva (formerly GE Healthcare Life Sciences) to develop an Affimer-based rapid test for the COVID-19 coronavirus infection.

The process of generating new Affimer reagents to detect the SARS-COV-2 viral antigen was started in mid-March, shortly before the Company announced its collaboration with Cytiva. Multiple highly specific Affimer binders have now been generated that bind to the spike proteins of the SARS-COV-2 virus and do not cross-react with other very closely related viruses, such as SARS and MERS.

These Affimer reagents will be characterised by Avacta with the aim of developing a laboratory test for the SARS-COV-2 virus antigen within the next few weeks. These Affimer binders will also be transferred to Cytiva shortly for implementation in a point-of-care test strip, similar in appearance to a pregnancy test, giving a visual read-out in minutes using a sample such as saliva.

Avacta owns the intellectual property relating to the SARS-COV-2 Affimer reagents and retains all commercial rights. Avacta is in active discussion with other global diagnostic companies to develop Affimer-based COVID-19 antigen tests to increase high-throughput testing capacity on a world-wide scale.

Dr Alastair Smith, Chief Executive Officer of Avacta Group, commented:

"The speed with which highly specific Affimer reagents can be generated is just one of the many significant advantages of the technology. I would like to publicly thank Avacta colleagues who have worked long hours and weekends to make astounding progress and generate Affimer reagents against a novel virus in only four weeks and well ahead of schedule.

The need for rapid antigen tests to diagnose COVID-19 infection that can be mass produced for rapid, professional screening of large populations, and for self-testing by consumers themselves, is crucial to limiting and tracking the spread of this disease. Antigen testing will also be critical to lockdown exit strategies around the world in order to get healthy, non-contagious people back to work to re-boot economies, and there will be an ongoing need for several years for antigen testing as the disease recurs.

We have made an excellent st

Apologies Should be Roche.

https://twitter.com/avacta?lang=en

https://www.reuters.com/article/us-health-coronavirus-vaccines-idUSKBN28I1YM?taid=5fcf9ad7f0e12b00013d94a8&utm_campaign=trueAnthem:+Trending+Content&utm_medium=trueAnthem&utm_source=twitter

Thank you for your in depth analysis.

How will they know which of the 90% are immune after receiving vaccine - Oh, by TESTING
How will they know which of the initial 450,000 immune candidates retain immunity over time - now let me see, Oh, TESTING again.
And then there will be ultimately the say 30,000,000 who will need repeat TESTING as above.
And then there's the rest of the country (30,000,000) that declines to take the vaccine, who will need TESTING.
So, rather surprising then that the market has written off all the companies like ODX, Avacta, Novacyt, Synairgen, 4D because they specialise in TESTING.
Patience

43,000 people tested but only followed up for a week.. What like Thalidomide?
Only 90% effective.
So of 40,000,000 tests ordered we might get a million by the year end. 1,000,000 tests works for 500,000 people.
Of those 500,000 50,000 will be wandering the streets of the UK thinking they are immune but won't be.

Timing of announcement is obviously premature as a boost for Biden (I am a fan) providing a boost for large corporate stocks globally.
The effect on AIM testing stocks is a ridiculous over-reaction when testing will still be needed for years eventually the prices should recover. Chill

From today's Express "Meanwhile a man working in Maidstone, Kent, was forced to make a round trip of more than 400 miles for a virus test - only for his results never to arrive."

HL are worse than sh--te

If we are included in Falcon then we should also be included in Raptor.
https://www.condor-platform.org/condor_workstreams/raptor/raptor-c19

Try a website called 247spares

Just spent maybe 5 minutes talking up the Avacta test without naming it on BBC Radio 5 just after 3am

Then the next consideration will be how wide is the spread.

I am a relative newcomer to the world of bulletin boards. I find some gems of advice, but mostly nasty, vindictive, ill=informed, schoolboy niggling. Of all of the posters on the Eurasia site I find Rowka the most civilised, knowledgeable, informative and patient contributor. Just to say a big thank you for all you shared knowledge and expertise.

Just tried to buy on HL. Same result - can only sell.

Why are there so many a**e holes on here. The children haven't gone back to school. They are all posting stupid comments on here. Leave it out. Grow up please.

Yesterday's PM on Radio 4 https://www.bbc.co.uk/sounds/play/m000l0k4 starting at 39.06. Top men of Velocys, ITM and Inspa
ce got about a minute each to pitch the company.

Actually it is the Italian for speed - as in English velocity